Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Apyx Medical (APYX) over the last 16 years, with Q3 2025 value amounting to $25.1 million.

  • Apyx Medical's Cash & Current Investments fell 1027.38% to $25.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.1 million, marking a year-over-year decrease of 1027.38%. This contributed to the annual value of $31.7 million for FY2024, which is 2728.63% down from last year.
  • According to the latest figures from Q3 2025, Apyx Medical's Cash & Current Investments is $25.1 million, which was down 1027.38% from $29.3 million recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's Cash & Current Investments registered a high of $43.7 million during Q4 2023, and its lowest value of $10.2 million during Q4 2022.
  • For the 5-year period, Apyx Medical's Cash & Current Investments averaged around $27.5 million, with its median value being $29.3 million (2025).
  • In the last 5 years, Apyx Medical's Cash & Current Investments tumbled by 6698.41% in 2022 and then skyrocketed by 32829.67% in 2023.
  • Quarter analysis of 5 years shows Apyx Medical's Cash & Current Investments stood at $30.9 million in 2021, then plummeted by 66.98% to $10.2 million in 2022, then surged by 328.3% to $43.7 million in 2023, then fell by 27.29% to $31.7 million in 2024, then fell by 20.81% to $25.1 million in 2025.
  • Its Cash & Current Investments was $25.1 million in Q3 2025, compared to $29.3 million in Q2 2025 and $31.0 million in Q1 2025.